To this end, CAR-T cells expressing the IL-7Rα subunit (IL-7Rα-transgenic/CAR-redirected EBV-CTLs) were engineered and investigated against neuroblastoma cells in vivo and in vitro [81]. The gene discussed is IL7R; the disease is neuroblastoma.